A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

This study has been completed.
Sponsor:
Information provided by:
Quark Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00554359
First received: November 4, 2007
Last updated: February 22, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)